Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Carcinogenesis
|
November 1, 1995
The effects of cycloheximide and WR-1065 on radiation-induced repair processes: a mechanism for chemoprevention
J S Murley, D J Grdina
European Journal of Cancer (Oxford, England : 1990)
|
February 19, 1999
Genistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells
A I Constantinou, N Kamath, J S Murley
Drug Metabolism and Drug Interactions
|
February 24, 2001
Amifostine: mechanisms of action underlying cytoprotection and chemoprevention
D J Grdina, Y Kataoka, J S Murley
Radiation Research
|
May 1, 1991
Accumulation of CHO cells in G2 phase following exposure to WR-1065
J S Murley, D J Grdina, P J Meechan
Cell Proliferation
|
November 1, 1992
Effects of growth media on cell cycle progression in CHO cells exposed to the radioprotector WR-1065
J S Murley, D J Grdina, P J Meechan
Cell Proliferation
|
February 2, 1999
Effects of thiols on topoisomerase-II alpha activity and cell cycle progression
D J Grdina, J S Murley, J C Roberts
International Journal of Radiation Biology
|
June 24, 2000
Cytoprotection by WR-1065, the active form of amifostine, is independent of p53 status in human malignant glioma cell lines
Y Kataoka, J S Murley, R Patel, et al.
Radiation Research
|
April 1, 1994
Inhibition of topoisomerase II alpha activity in CHO K1 cells by 2-[(aminopropyl)amino]ethanethiol (WR-1065)
D J Grdina, A Constantinou, N Shigematsu, et al.
Cell Proliferation
|
June 1, 1997
WR-1065, an active metabolite of the cytoprotector amifostine, affects phosphorylation of topoisomerase II alpha leading to changes in enzyme activity and cell cycle progression in CHO AA8 cells
J S Murley, A Constantinou, N S Kamath, et al.
Carcinogenesis
|
February 5, 1998
Repression of c-myc gene expression by the thiol and disulfide forms of the cytoprotector amifostine
S C Liu, J S Murley, G Woloschak, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Carcinogenesis
|
November 1, 1995
The effects of cycloheximide and WR-1065 on radiation-induced repair processes: a mechanism for chemoprevention
J S Murley, D J Grdina
European Journal of Cancer (Oxford, England : 1990)
|
February 19, 1999
Genistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells
A I Constantinou, N Kamath, J S Murley
Drug Metabolism and Drug Interactions
|
February 24, 2001
Amifostine: mechanisms of action underlying cytoprotection and chemoprevention
D J Grdina, Y Kataoka, J S Murley
Radiation Research
|
May 1, 1991
Accumulation of CHO cells in G2 phase following exposure to WR-1065
J S Murley, D J Grdina, P J Meechan
Cell Proliferation
|
November 1, 1992
Effects of growth media on cell cycle progression in CHO cells exposed to the radioprotector WR-1065
J S Murley, D J Grdina, P J Meechan
Cell Proliferation
|
February 2, 1999
Effects of thiols on topoisomerase-II alpha activity and cell cycle progression
D J Grdina, J S Murley, J C Roberts
International Journal of Radiation Biology
|
June 24, 2000
Cytoprotection by WR-1065, the active form of amifostine, is independent of p53 status in human malignant glioma cell lines
Y Kataoka, J S Murley, R Patel, et al.
Radiation Research
|
April 1, 1994
Inhibition of topoisomerase II alpha activity in CHO K1 cells by 2-[(aminopropyl)amino]ethanethiol (WR-1065)
D J Grdina, A Constantinou, N Shigematsu, et al.
Cell Proliferation
|
June 1, 1997
WR-1065, an active metabolite of the cytoprotector amifostine, affects phosphorylation of topoisomerase II alpha leading to changes in enzyme activity and cell cycle progression in CHO AA8 cells
J S Murley, A Constantinou, N S Kamath, et al.
Carcinogenesis
|
February 5, 1998
Repression of c-myc gene expression by the thiol and disulfide forms of the cytoprotector amifostine
S C Liu, J S Murley, G Woloschak, et al.
Page
of 2